Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes.

Autor: Calabrese DR; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.; Department of Medicine, UCSF, San Francisco, California, USA., Tsao T; Department of Medicine, UCSF, San Francisco, California, USA., Magnen M; Department of Medicine, UCSF, San Francisco, California, USA., Valet C; Department of Medicine, UCSF, San Francisco, California, USA., Gao Y; Department of Medicine, UCSF, San Francisco, California, USA., Mallavia B; Department of Medicine, UCSF, San Francisco, California, USA., Tian JJ; Department of Medicine, UCSF, San Francisco, California, USA., Aminian EA; Department of Medicine, UCSF, San Francisco, California, USA., Wang KM; Department of Medicine, UCSF, San Francisco, California, USA., Shemesh A; Department of Medicine, UCSF, San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Punzalan EB; Department of Medicine, UCLA, Los Angeles, California, USA., Sarma A; Department of Medicine, UCSF, San Francisco, California, USA., Calfee CS; Department of Medicine, UCSF, San Francisco, California, USA., Christenson SA; Department of Medicine, UCSF, San Francisco, California, USA., Langelier CR; Department of Medicine, UCSF, San Francisco, California, USA., Hays SR; Department of Medicine, UCSF, San Francisco, California, USA., Golden JA; Department of Medicine, UCSF, San Francisco, California, USA., Leard LE; Department of Medicine, UCSF, San Francisco, California, USA., Kleinhenz ME; Department of Medicine, UCSF, San Francisco, California, USA., Kolaitis NA; Department of Medicine, UCSF, San Francisco, California, USA., Shah R; Department of Medicine, UCSF, San Francisco, California, USA., Venado A; Department of Medicine, UCSF, San Francisco, California, USA., Lanier LL; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Department of Microbiology and Immunology and., Greenland JR; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.; Department of Medicine, UCSF, San Francisco, California, USA., Sayah DM; Department of Medicine, UCLA, Los Angeles, California, USA., Ardehali A; Department of Medicine, UCLA, Los Angeles, California, USA., Kukreja J; Department of Surgery, UCSF, San Francisco, California, USA., Weigt SS; Department of Medicine, UCLA, Los Angeles, California, USA., Belperio JA; Department of Medicine, UCLA, Los Angeles, California, USA., Singer JP; Department of Medicine, UCSF, San Francisco, California, USA., Looney MR; Department of Medicine, UCSF, San Francisco, California, USA.

Publikováno v: JCI insight [JCI Insight] 2022 Dec 22; Vol. 7 (24). Date of Electronic Publication: 2022 Dec 22.

Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.

Autor: Weigt SS; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Kim GJ; Department of Radiology, University of California Los Angeles, Los Angeles, CA., Jones HD; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA., Ramsey AL; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Amubieya O; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Abtin F; Department of Radiology, University of California Los Angeles, Los Angeles, CA., Pourzand L; Department of Radiology, University of California Los Angeles, Los Angeles, CA., Lee J; Department of Radiology, University of California Los Angeles, Los Angeles, CA., Shino MY; Department of Medicine, University of California Los Angeles, Los Angeles, CA., DerHovanessian A; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Stripp B; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA., Noble PW; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA., Sayah DM; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Saggar R; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Britton I; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Lynch JP 3rd; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Belperio JA; Department of Medicine, University of California Los Angeles, Los Angeles, CA., Goldin J; Department of Radiology, University of California Los Angeles, Los Angeles, CA.

Publikováno v: Transplantation [Transplantation] 2022 Jun 01; Vol. 106 (6), pp. 1253-1261. Date of Electronic Publication: 2022 May 23.

The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.

Autor: Shino MY; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Zhang Q; Department of Immunogenetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Li N; Department of Biomathematics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Derhovanessian A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Ramsey A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Saggar R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Britton IN; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Amubieya OO; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Lari SM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Hickey M; Department of Immunogenetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Reed EF; Department of Immunogenetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Noble PW; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA., Stripp BR; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA., Fishbein GA; Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Lynch JP 3rd; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Ardehali A; Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Sayah DM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Weigt SS; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Belperio JA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2022 Feb; Vol. 22 (2), pp. 565-573. Date of Electronic Publication: 2021 Nov 12.